Form 6-K ONCOLYTICS BIOTECH INC For: Feb 25

Go back to Form 6-K ONCOLYTICS BIOTECH INC For: Feb 25

BeiGene Ltd. (ONC) PT Raised to $308 at Jefferies

February 27, 2025 3:36 PM EST

Jefferies analyst Kelly Shi raised the price target on BeiGene Ltd. (NASDAQ: ONC) to $308.00 (from $286.00) while maintaining a Buy rating.

The analyst comments "ONC posted strong FY results, with $3.8B FY rev (+55% YoY, vs $3.7B cons). Despite investor discussion of script discrepancies, Brukinsa... More